Evaxion Biotech A/S announced a private placement on December 18, 2023, selling nearly 9.73 million ordinary shares at about $0.544 each, increasing its share capital to DKK 37,906,996. Following an Extraordinary General Meeting on January 11, 2024, plans for further share capital increases and warrant issuances were approved, targeting DKK 47 million.